Natrixam (Indapamide, Amlodipine Besilate)

Indapamide and Amlodipine Besilate, the active ingredients in Natrixam, are a combination antihypertensive presented as an oral tablet for systemic use. They treat hypertension in adult patients by reducing blood pressure through complementary mechanisms.

GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natrixam is a combination antihypertensive that lowers elevated blood pressure through diuretic and vasodilatory actions.

- Essential hypertension: reduces both systolic and diastolic pressure in primary hypertension. - Isolated systolic hypertension: provides arterial vasodilation and volume reduction to control high systolic values. - Secondary hypertension (e.g., renal): assists in blood pressure control when used with other agents.

Common Side Effects: - Dizziness or light‑headedness - Headache - Peripheral edema - Flushing - Fatigue - Palpitations

Serious or Rare Side Effects: - Severe hypotension - Electrolyte disturbances such as hyponatremia or hypokalemia - Angioedema - Hepatic dysfunction - Pancreatitis - Anaphylactic reactions

Before initiating therapy, consider the following precautions: - Monitor blood pressure: check regularly after starting treatment. - Assess renal function: adjust use if renal impairment is present. - Electrolyte monitoring: watch for sodium and potassium changes. - Avoid abrupt discontinuation: may cause rebound hypertension. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

When prescribing Natrixam, be aware of potential drug interactions.

Major Interactions (Avoid): - Concomitant use with other antihypertensives may cause excessive hypotension. - Lithium therapy may lead to elevated lithium concentrations. - NSAIDs may blunt the diuretic effect and increase renal risk.

Moderate Interactions (Monitor Closely): - Potassium‑sparing diuretics may increase serum potassium levels. - CYP3A4 inhibitors (e.g., erythromycin) may raise amlodipine concentrations.